IM Cannabis Corp., a leading medical cannabis company operating in Israel and Germany, has appointed Shmulik Arbel to its board of directors. Arbel brings extensive experience in strategic planning, finance, and corporate governance, further solidifying the company’s commitment to growth and sustainable profitability.